GlycoMimetics Inc (GLYC)

0.242 +0.03 (+11.78%) USD  |  NASDAQ  |  Dec 24, 16:00
More

GlycoMimetics Free Cash Flow to Equity (Quarterly)

Free Cash Flow to Equity (Quarterly) Chart

View Free Cash Flow to Equity (Quarterly) for GLYC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow to Equity (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Free Cash Flow to Equity Definition

View Free Cash Flow to Equity Definition
Start Trial

Free cash flow to equity measures the total free cash flow divided by shareholder's equity. This metric can be used as a gauge for cash flow available for shareholders.

Read full definition.

Free Cash Flow to Equity (Quarterly) Range, Past 5 Years

View Free Cash Flow to Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow to Equity (Quarterly) Benchmarks

View Free Cash Flow to Equity (Quarterly) Benchmarks
Start Trial
Biomarin Pharmaceutical Inc Upgrade
Arbutus Biopharma Corp Upgrade
Revance Therapeutics Inc Upgrade
FibroGen Inc Upgrade
Cidara Therapeutics Inc --

Free Cash Flow to Equity (Quarterly) Related Metrics

Cash from Operations (Quarterly) Upgrade
Free Cash Flow Upgrade
Free Cash Flow Per Share (Quarterly) Upgrade
Free Cash Flow Yield Upgrade